These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15334628)

  • 1. Rationale for superficial injection techniques in lymphatic mapping in breast cancer patients.
    Nieweg OE; Estourgie SH; van Rijk MC; Kroon BB
    J Surg Oncol; 2004 Sep; 87(4):153-6. PubMed ID: 15334628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
    Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
    Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axillary and extra-axillary lymph node recurrences after a tumor-negative sentinel node biopsy for breast cancer using intralesional tracer administration.
    van der Ploeg IM; Kroon BB; Antonini N; Valdés Olmos RA; Rutgers EJ; Nieweg OE
    Ann Surg Oncol; 2008 Apr; 15(4):1025-31. PubMed ID: 18219534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
    Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
    J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additional tracer injection to improve the technical success rate of lymphoscintigraphy for sentinel node biopsy in breast cancer.
    Heuts EM; van der Ent FW; van der Pol HA; von Meyenfeldt MF; Voogd AC
    Ann Surg Oncol; 2009 May; 16(5):1156-63. PubMed ID: 19259741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer.
    Povoski SP; Olsen JO; Young DC; Clarke J; Burak WE; Walker MJ; Carson WE; Yee LD; Agnese DM; Pozderac RV; Hall NC; Farrar WB
    Ann Surg Oncol; 2006 Nov; 13(11):1412-21. PubMed ID: 16957969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-axillary breast cancer recurrences after sentinel node biopsy.
    van Rijk MC; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Hoefnagel CA; Kroon BB
    J Surg Oncol; 2005 Dec; 92(4):292-8. PubMed ID: 16299804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Letter to the editor concerning 'intradermal radioisotope injection optimises sentinel lymph node identification in breast cancer'.
    Nieweg OE; Tanis PJ
    Eur J Surg Oncol; 2004 Aug; 30(6):708-9. PubMed ID: 15256248
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with intradermal injection and intradermal-plus-deep injection in the radioguided sentinel node biopsy of early breast cancer patients.
    Koizumi M; Koyama M; Yamashita T; Tada KI; Nishimura SI; Takahashi K; Makita M; Iwase T; Yoshimoto M; Kasumi F
    Eur J Surg Oncol; 2006 Sep; 32(7):738-42. PubMed ID: 16806793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double mapping with subareolar blue dye and peritumoral green dye injections decreases the false-negative rate of dye-only sentinel node biopsy for early breast cancer: 2-site injection is more accurate than 1-site injection.
    Anan K; Mitsuyama S; Kuga H; Saimura M; Tanabe Y; Suehara N; Matsunaga H; Nishihara K; Abe Y; Iwashita T; Ihara T; Tamae K; Ono M; Toyoshima S
    Surgery; 2006 May; 139(5):624-9. PubMed ID: 16701094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blue-dye technique complements four-node sampling for early breast cancer.
    Ishikawa T; Momiyama N; Hamaguchi Y; Tanabe M; Tomita S; Ichikawa Y; Nakatani Y; Sasaki T; Nozawa A; Inayama Y; Inui K; Shimada H
    Eur J Surg Oncol; 2005 Dec; 31(10):1119-24. PubMed ID: 16005597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary recurrences after negative sentinel lymph node biopsy under local anaesthesia for breast cancer: a follow-up study after 5 years.
    Groetelaers RP; van Berlo CL; Nijhuis PH; Schapers RF; Gerritsen HA
    Eur J Surg Oncol; 2009 Feb; 35(2):159-63. PubMed ID: 18789841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
    Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
    Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New approaches in breast cancer management: sentinel node biopsy and intraoperative radiotherapy.
    Keshtgar MR; Chicken DW; Tobias JS
    Int J Fertil Womens Med; 2005; 50(5 Pt 1):218-26. PubMed ID: 16468472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramammary lymph node metastasis of breast cancer after sentinel node biopsy: two cases and a review of the literature.
    Araújo C; Fougo JL
    Eur J Surg Oncol; 2009 Dec; 35(12):1354. PubMed ID: 19592195
    [No Abstract]   [Full Text] [Related]  

  • 17. A concordance study of subareolar and subdermal injections for breast cancer sentinel lymph node mapping.
    Gray RJ; Pockaj BA
    Am J Surg; 2004 Oct; 188(4):423-5. PubMed ID: 15474440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic drainage patterns in breast cancer patients who previously underwent mantle field radiation.
    van der Ploeg IM; Russell NS; Nieweg OE; Oldenburg HS; Kroon BB; Olmos RA; Rutgers EJ
    Ann Surg Oncol; 2009 Aug; 16(8):2295-9. PubMed ID: 19452228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of sentinel lymph node biopsy in early breast cancer.
    Jatoi I
    Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
    Gipponi M
    Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.